Novo Holdings A/S’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Novo Holdings A/S’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,100,000	Closed	-$6.55M	–	42
2023 Q2	$6.55M	Sell	2,100,000 -359,021	-15%	-$1.07M	0.51%	35
2023 Q1	$6.3M	Hold	2,459,021	–	–	0.42%	39
2022 Q4	$3.66M	Hold	2,459,021	–	–	0.23%	45
2022 Q3	$4.28M	Hold	2,459,021	–	–	0.2%	48
2022 Q2	$3.2M	Hold	2,459,021	–	–	0.16%	51
2022 Q1	$5.85M	Hold	2,459,021	–	–	0.31%	42
2021 Q4	$11.3M	Hold	2,459,021	–	–	0.53%	29
2021 Q3	$19.9M	Hold	2,459,021	–	–	1.03%	22
2021 Q2	$24.2M	Hold	2,459,021	–	–	1.07%	22
2021 Q1	$21.7M	Sell	2,459,021 -500,000	-17%	-$5.49M	0.9%	23
2020 Q4	$30.3M	Sell	2,959,021 -450,000	-13%	-$4.92M	1.3%	20
2020 Q3	$30.8M	Hold	3,409,021	–	–	1.53%	15
2020 Q2	$24.3M	Hold	3,409,021	–	–	1.57%	13
2020 Q1	$32.4M	Hold	3,409,021	–	–	2.16%	8
2019 Q4	$44.9M	Buy	+3,409,021	New	+$41.6M	2.89%	7

Other funds holding GRTX

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFGH

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Novo Holdings A/S's GRTX Position: Q3 2023 in Review

Novo Holdings A/S sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q3 2023, closing a stake of 2,100,000 shares — an estimated $6.55M sold.

Novo Holdings A/S first reported a position in GRTX in Q4 2019 and held it in 15 quarters. The position peaked at $44.9M in Q4 2019. 38 funds tracked by Wall St. Rank hold GRTX as of Q3 2023.

Novo Holdings A/S reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Novo Holdings A/S sold 2,100,000 Galera Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.55M.
Novo Holdings A/S first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 15 quarters.
Novo Holdings A/S's Galera Therapeutics, Inc. Common Stock position peaked at $44.9M in Q4 2019.
38 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Novo Holdings A/S's 13F filing for Q3 2023, filed 14 Nov 2023.